Results 221 to 230 of about 126,848 (290)

The THESEUS Space Mission and the Infrared Telescope Calibration Unit

Astronomische Nachrichten, EarlyView.
ABSTRACT The Transient High‐Energy Sky and Early Universe Surveyor (THESEUS) is an ESA M7 mission concept currently in Phase A, designed to exploit gamma‐ray bursts to probe the early Universe while advancing multi‐messenger and time‐domain astrophysics. To achieve its ambitious goals, THESEUS will combine wide‐band x‐ray and gamma‐ray monitors with an
András Péter Joó, Rebeka Gyöngyi Kiss, Lorenzo Amati, Bendegúz Koncz, Örs Detre, Gyula Zilizi, Zsolt Bagoly, István I. Rácz, Sándor Pintér, L. Viktor Tóth   +9 more
wiley   +1 more source

Alginate-Poly[2-(methacryloyloxy)ethyl]trimethylammonium Chloride (PMETAC) Immunoisolating Capsules Prolong the Viability of Pancreatic Islets In Vivo. [PDF]

Biomedicines
Ermakova P, Vasilchikova E, Potapov A, Baten'kin M, Lugovaya L, Bogomolova A, Tselousova J, Konev A, Anisimova N, Egoshina A, Zakharina M, Naraliev N, Kuchin D, Zagainov V, Chesnokov S, Kashina A, Zagaynova E.   +16 more
europepmc   +1 more source

A systematic scoping review of metrics utilized to measure antibiotic consumption in hospital settings

British Journal of Clinical Pharmacology, EarlyView.
Abstract Antimicrobial stewardship (AMS) programs were introduced to promote the judicious use of antimicrobials and to combat antimicrobial resistance. Quantifying antibiotic consumption is an important part of AMS initiatives to achieve these objectives.
Marjan Kandimahforoujaki, Kiplin A. Patanwala, Jan‐Willem C. Alffenaar, Asad E. Patanwala   +3 more
wiley   +1 more source

A novel homozygous splice-site variant in the FOCAD gene causing infantile liver cirrhosis and neutropenia: expanding disease phenotype and successful surgical treatment. [PDF]

Front Med (Lausanne)
Nuzhnaya E, Zaklyazminskaya E, Zabnenkova V, Akimova D, Tatarsky E, Dzik L, Surkov A, Zhurkova N, Filin A, Metelin A, Arakelyan A, Savina V, Babayan A, Skoblov M, Semenova N.   +14 more
europepmc   +1 more source

INFLUENCE OF BUDGETARY FUNDS USAGE EFFICIENCY ON FINANCIAL STABILITY INDICATORS OF AGRICULTURAL ORGANIZATIONS

Bulletin of the Moscow University named S U Vitte Series 1 Economics and management, 2019
openaire   +1 more source

Status of oncology drugs with a conditional approval: A cross‐sectional comparison of the Food and Drug Administration and Health Canada

British Journal of Clinical Pharmacology, EarlyView.
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley   +1 more source

Porous Osteoplastic Composite Materials Based on Alginate-Pectin Complexes and Cation-Substituted Hydroxyapatites. [PDF]

Polymers (Basel)
Davydova GA, Fadeeva IV, Trofimchuk ES, Selezneva II, Mahamadiev MT, Akhmetov LI, Yakovsky DS, Proskurin VP, Fosca M, Yankova VG, Rau JV, Saceleanu V.   +11 more
europepmc   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Immediate full weightbearing with additive cerclage improves early mobility after tibial shaft spiral fractures. [PDF]

Sci Rep
Lisitano L, Röttinger T, Eger S, Neuerburg C, Mayr E, Förch S.   +5 more
europepmc   +1 more source

Full text and summary of an address [presenting Commission program for 1984] by Gaston Thorn, President of the Commission of the European Communities, to the European Parliament. Strasbourg, 15 February 1984 [PDF]

, 1984
Thorn, Gaston.
core